Proteomics

Dataset Information

0

CD209L/L-SIGN N-Glycosylation and N-Glycosylation Site Occupancy


ABSTRACT: CD209L is a membrane glycoprotein with known glycan-binding properties and it also contains 2 N-glycosylation sequons at sites N92 and N361. Treatment with PNGase F in the presence of H218O, which removes N-linked glycans and isotopically labels the formerly-glycosylated site, confirmed that both unmodified and formerly-glycosylated versions of the peptide spanning the N92 N-glycosylated sequon were present. This suggests that a portion of CD209L protein is N-glycosylated at site N92. nUPLC-MS/MS analyses of CD209L digests enabled detection of a glycopeptide consistent with high-mannose type N-linked glycosylation.

INSTRUMENT(S): Orbitrap Fusion Lumos

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Cell Culture

SUBMITTER: Kevin Chandler  

LAB HEAD: Catherine E Costello

PROVIDER: PXD021309 | Pride | 2021-09-09

REPOSITORIES: Pride

altmetric image

Publications


As the COVID-19 pandemic continues to spread, investigating the processes underlying the interactions between SARS-CoV-2 and its hosts is of high importance. Here, we report the identification of CD209L/L-SIGN and the related protein CD209/DC-SIGN as receptors capable of mediating SARS-CoV-2 entry into human cells. Immunofluorescence staining of human tissues revealed prominent expression of CD209L in the lung and kidney epithelia and endothelia. Multiple biochemical assays using a purified reco  ...[more]

Similar Datasets

2019-01-24 | PXD010911 | Pride
2024-01-26 | PXD035935 | Pride
2021-06-14 | PXD024835 | Pride
2020-03-26 | PXD017060 | Pride
2021-09-08 | PXD012629 | Pride
2023-03-03 | PXD037378 | Pride
2015-12-09 | E-MTAB-2401 | biostudies-arrayexpress
2022-09-01 | E-MTAB-12163 | biostudies-arrayexpress
2016-03-18 | PXD002215 | Pride
2023-04-23 | PXD039002 | Pride